Mrs. S. is a 37-year-old Caucasian female who sought care at her home institution overseas during a period of several months for complaints of esophageal reflux, constipation, early satiety, increasing abdominal girth, and fatigue.
You are a Registered Nurse working in a busy oncology unit. While assessing one of your patients, you notice that the bag of morphine used in his patient-controlled analgesia (PCA) system is running low.
On February 16, 2010, a Risk Evaluation and Mitigation Strategies (REMS) program to ensure safe use of erythropoiesis-stimulating agents (ESAs) was approved by the US Food and Drug Administration (FDA).
Approved Drugs: Pazopanib (Votrient) Indications
More than 2.5 million breast cancer survivors live in the US today. This number will continue to grow thanks to early detection and advances in treatment that are making early stage breast cancer an increasingly curable disease.
When she learned that she had breast cancer, Patricia Garrett did what many people with cancer do: she continued working.
With about 12 million cancer survivors living in the US, cancer affects millions of working Americans. Improvements in early detection and treatment have resulted in a significant number of newly diagnosed and long-term survivors of working age.
The May 2010 theme of Oncology Nursing Month is “Oncology Nurses: There When You Need Us.”
An estimated 219,440 new cases of lung cancer were expected in 2009, accounting for about 15% of cancer diagnoses.
The patient, “TB,” is a 44-year-old Caucasian, married woman with three daughters, 21, 18, and 10 years of age.